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ARTICLE INFO  ABSTRACT 
The prevalence rate of HIV/AIDS and various achievement targets are still 
challenges in HIV/AIDS intervention in Indonesia. Indonesia is required to 
map out the current resources and their allocation in dealing with HIV 
AIDS. The objective of this study is to know the distribution and the factors 
that related with the HIV/AIDS expenditure in the year 2010-2018. This 
study uses a correlation study design derived from the 2019 National AIDS 
Spending Assesment (NASA) report and other data sources. The results of 
the study show that the total expenditure on HIV/AIDS programs in 2017 
was 143,053,754 USD and decreased to 107,680,959 USD in 2018. Of the 
total expenditure, about 60% each came from public funding, an increase 
of 30% over 10 years. There is a strong relationship between HIV expendi-
ture and the variables of reported HIV cases, ARV coverage, GDP growth 
and health budget. Total domestic expenditure on HIV and the total health 
budget had the strongest relationship (R=0.885) with a contribution of 
78.3% effect on the health budget (p=0.001). The availability of domestic 
funds is still limited and is dominated by the allocation of treatment. The 
high level of dependence on international funding especially on prevention 
means that the architecture of HIV/AIDS funding needs to be reorganized 
to protect the sustainability of HIV funding. 
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Tingkat prevalensi HIV/AIDS dan berbagai target capaian program masih 
menjadi tantangan penanggulangan HIV/AIDS di Indonesia. Indonesia perlu 
memetakan sumberdaya yang ada saat ini serta alokasinya dalam penang-
gulangan HIV AIDS. Tujuan penelitian ini adalah mengetahui distribusi dan 
faktor-faktor yang berhubungan dengan pengeluaran dana HIV/AIDS tahun 
2010-2018. Penelitian ini menggunakan desain studi korelasi yang berasal 
dari laporan NASA 2019 serta sumber data lainnya. Hasil penelitian me-
nunjukkan bahwa total pengeluaran program HIV/AIDS pada 2017 adalah 
143,053,754 USD dan turun menjadi 107,680,959 USD di 2018. Dari total 
pengeluaran, masing-masing sekitar 60% berasal dari pendanaan publik, 
meningkat 30% selama 10 tahun. Terdapat hubungan yang kuat antara pen-
geluaran HIV dengan variabel kasus HIV terlapor, cakupan ARV, pertumbu-
han GDP serta anggaran kesehatan. Total pengeluaran domestik HIV dan to-
tal anggaran kesehatan memiliki hubungan yang paling kuat (R=0.885) den-
gan kontribusi pengaruh anggaran kesehatan sebesar 78.3% (p=0.001). Ke-
tersediaan dana domestik yang ada masih terbatas dan didominasi alokasi 
pengobatan. Tingkat ketergantungan yang tinggi pada pendanaan inter-
nasional khususnya pada pencegahan membuat arsitektur pendanaan 
HIV/AIDS perlu diatur ulang untuk melindungi keberlanjutan pendanaan 
HIV. 





     Indonesia, with a population of around 230 
million people, faces its own challenges related 
to the HIV pandemic. Since it was discovered in 
1987, the cumulative number of HIV cases in 
Indonesia until December 31, 2018 reached 
327,282 cases.1 Similarly, the number of AIDS 
cases in December 2018 was 114,065 people.2 
The number of HIV cases found and reported is 
still far from the estimated number of HIV cases. 
It is estimated that there were 630,000 people 
living with HIV/AIDS (PLWHA) in 2018 which 
means that only 50% are currently being found.3 
In addition to the challenges in case finding, In-
donesia also faces challenges in the treatment of 
Anti-Retroviral (ARV) drugs. Not all people diag-
nosed with HIV receive ARV therapy (about 70% 
have received ARV treatment and only 33% are 
receiving regular ARV treatment). The highest 
transmission of AIDS cases occurred through 
sexual intercourse (70.2%), injecting drug users 
(8.2%), homosexual relations (7%), and perina-
tally (2.9%).4 The highest proportion of patients 
was found in the 25-49 year age group (69.6%), 
followed by the age group 20-29 years (15.6%), 
and the age group >49 years (8.3%). Currently, 
Indonesia is the only country in the Asia-Pacific 
region where the prevalence of HIV is still in-
creasing and it is estimated that as many as 
630,000 people were living with HIV AIDS in 
2018.1,2 
     On the one hand, Indonesia has achieved the 
status of an upper-middle-income economy, as 
stated by the World Bank some time ago. This 
means that Indonesia which has a higher Gross 
National Index per capita (>3.630 USD) is no 
longer eligible to receive Global Fund support in 
HIV/AIDS control programs.3  
     Since 2004, UNAIDS has developed an instru-
ment used to estimate the amount of spending 
on HIV/AIDS control in a country called the Na-
tional AIDS Spending Assessment (NASA). NASA 
is an approach to identifying how much to spend 
on HIV/AIDS programs using international 
standard account codes. The results of this anal-
ysis are useful for comparing expenditures be-
tween countries, in addition to the specific goal 
that the estimation results meet the limits for 
standard activities of HIV/AIDS programs.4,5 In 
addition, the results from NASA can be used to 
estimate gaps and future planning and 
budgeting related to the HIV/AIDS program 
response.6,7 This research using the NASA 
method aims to analyze whether Indonesia can 
independently finance its HIV/AIDS control pro-
gram in 2020. 
MATERIAL AND METHOD 
     This research is an analytical research with a 
correlation study design. The data used are se-
condary data from the 2019 National AIDS 
Spending Assessment (NASA) and the Quarterly 
HIV AIDS report from the Indonesian Ministry of 
Health for case reports and ARV coverage. Explo-
ration of health budget data sourced from the In-
donesian Health Profile report. Finally, Gross 
Domestic Product (GDP) growth data is obtained 
from the official website of the World Bank.5 
     The NASA method is an approach to exploring 
information on HIV and AIDS program spending 
from various dimensions. The data collected in 
this study comes from data on main funding 
sources and data on program expenditures at 
the central level; data at the sub-national level, 
namely the provincial and district levels; as well 
as data from international and private partner 
institutions. 
     The data that has been obtained from these 
two sources are then performed with univariate 
analysis and bivariate analysis using linear 
regression analysis. The variable of the bivariate 
analysis is the total expenditure of HIV AIDS 
funds withReported HIV cases, ARV coverage, 
GDP growth and health budget. The time of the 
analysis is from 2010 to 2018. 
RESULT 
     Broadly speaking, spending on HIV AIDS pro-
grams in Indonesia increased from 2010 to 
2016, this trend then declined in 2017-2018 
(Figure 1). In 2017 the total expenditure on HIV 
AIDS in Indonesia was USD 142,126.615, a de-
crease compared to 2016 which was 
177,363,486 and in 2018, this figure decreased 
again to USD 108,607,097. Overall, the contribu-
tion of the Indonesian government (or public 
funds) covering expenditures at the central and 
provincial/district/city levels in 2013 to 2018 
accounted for more than half of the total funding 
(Figure 2).
  




Source: Secondary Data of NASA, 2019 
 
Figure 1. Total HIV/AIDS Program Expenditure 
in Indonesia 2010-2018 
Source: Secondary Data of NASA, 2019 
 
Figure 2. Expenditures on HIV/AIDS Programs 
in Indonesia in 2010-2018 Based on Funding 
Sources 
     Based on Table 1 Distribution of HIV/AIDS 
Program Expenditures by Program Category, 
Service Providers and Funding Sources in 2017-
2018 shows the distribution of HIV/AIDS pro-
gram expenditures by program category. Of all 
activities funded in 2017, expenditures for the 
category of care and treatment were the largest 
(67.89%); followed by spending on program 
management and administrative strengthening 
(12.53%); and HR incentives (5.34%). The least 
expenditure is 0.17% for vulnerable groups and 
orphans. Based on funding sources, funds from 
international partner institutions were used 
more for program management and administra-
tive strengthening (36.16%) than for the cate-
gory of treatment and care (17.4%). While the 
source of funds from the community is mostly 
used for the category of treatment and care 
(91.48%) than other programs. The proportion 
of public funding sources and international 
institutions according to service providers as 
users in 2018, it can be seen that most of the 
public funding sources are used by public 
service providers (99.98%) and only 0.02% is 
used by private service providers. Meanwhile, 
international funding sources are mostly used 
by public service providers (41.49%) (Table 1). 
     Figure 3 shows the number of reported HIV 
cases at the Ministry of Health and the number 
of PLWHA on ARV treatment in 2010, reported 
HIV cases were 49,027 cases and in 2018 the 
number of cases increased to 341,061 cases. Of 
this number 40% or 19,572 underwent ARV 
treatment in 2010 and 108,479 (38%) in 2018. 
Although it increases every year, ARV coverage 
tends to be constant at 35-40% of the total HIV 
positive. 
      As with the increase in HIV transmission 
from the domestic budget, the health budget in-
creased from 2010 to 2018 (Table 2). In 2010, 25 
trillion was allocated for health. In 2014, the 
budget doubled to 50 trillion and in 2018, the 
health budget was allocated 62 trillion, in the 
same table, we can see that GDP growth in Indo-
nesia in general decreased slightly, in 2010, GDP 
in Indonesia experienced a growth of 6.22%, and 
in 2018, decreased to 5.17%. 
 
Source: Secondary Data of NASA, 2019 
 
Figure 3. Cases of HIV and People with HIV AIDS 






















     Based on the results of the correlation test, 
which can be seen in Table 3, the significance 
value for both total and domestic HIV expendi-
ture variables with reported HIV cases, ARV cov-
erage, GDP growth and health budget has a value 
smaller than 0.05. So, it can be concluded that 
there is a significant relationship between the 
two variables. Overall, the value of the relation 
coefficient is above 7, which means that there is 
a strong relationship between HIV expenditure 
and reported HIV cases, ARV coverage, GDP 
growth and health budget. Total domestic HIV 
expenditure and total health budget have a very 
strong relationship (R=0.885) with the contribu-
tion of the influence of the health budget of 
78.3%. 
 





Health Budget  
(Million) 
2010 6.22 25,274,804 
2011 6.17 30,919,270 
2012 6.03 33,293,456 
2013 5.56 38,636,739 
2014 5.01 50,335,789 
2015 4.88 54,337,519 
2016 5.03 65,662,593 
2017 5.07 59,114,104 
2018 5.17 61,864,479 
Source: Secondary Data of World Bank, 2019 & Indonesia 
Health Profile, 2019
  
Table 1. Distribution of HIV/AIDS Program Expenditures by Program Category, Service Providers and 
Funding Sources (2017-2018) 
Categories and Service Providers 
Sources of Funding 
Total 
Public International 
USD % USD % USD % 
2017 
Prevention 2,916,105 3.97 7,523,992 21.95 10,440,097 9.7 
Care and Treatment 67,139,988 91.48 5,966,963 17.4 73,106,951 67.89 
Vulnerable Groups and Orphans 179.090 0.24 0 0 179.090 0.17 
Program Management and Adminis-
tration Strengthening 
1,100,135 1.5 12,397,405 36.16 13,497,540 12.53 
Human Resources 1,559,853 2.13 4,188,734 12.22 5,748,587 5.34 
Social Protection and Services 269,645 0.37 36,272 0.11 305,917 0.28 
Enabling Environment 212,659 0.29 2,926,327 8.54 3,138,987 2.92 
Study 19,231 N/A 1,224,559 3.63 1,263,790 1.17 
Total 73,396,707 100 34,284,252 100 107,680,959 100 
2018 
PS.01 Public Service Provider 73,379,451 99.98 14,223,825 41.49 87,603,276 81.35 
PS.02 Private Service Provider 17,256 0.02 7,545,920 22.01 7,563,176 7.02 
PS.03 Bilateral & Multilateral Entities 0 0 12,514,507 36.5 12,514,507 11.62 
Total 73,396,707 100 34,284,252 100 107,680,959 100 













     Public funding has increased gradually since 
2006 and exceeded more than 60% of total 
spending in the 2015-2018 period. This funding 
consists of central ministries and agencies 
(85%), while local governments are 10% and 
5% from Badan Penyelenggaraan Jaminan Sosial 
Kesehatan (BPJS Kesehatan).6 Thus, the role of 
sub national and other private funding contribu-
tions should be increased.8 Basically public fund-
ing consists of 3 types, namely funds from the 
central government, provincial and district/city 
governments, as well as funds from community 
contributions through the national health insu-
rance program BPJS Kesehatan. 
     Most of the program expenditure carried out 
by domestic funds focuses on care and treatment 
activities (91.48% in 2017) while the largest in-
ternational funds were on prevention spending 
(21.95%) and program management and ad-
ministrative strengthening (36.16%).7 Expendi-
tures in the program management and adminis-
trative strengthening categories focus on: 
planning, coordination, and program mana-
gement; administrative and transaction costs 
related to funding; monitoring and evaluation; 
sero-surveillance; HIV-drug resistance super-
vision; drug supply system; information Tech-
nology; patient tracking; infrastructure im-
provement and construction; HIV testing and 
management/administrative matters.9 






Reported HIV cases - 
Total HIV Expenditure 
0.035 0.703 0.490 
Number of HIV patients 
on ARV treatment - To-
tal HIV Domestic Ex-
penditure 
0.034 0.700 0.495 
Reported HIV cases - 
Total HIV Domestic Ex-
penditure 
0.030 0.717 0.513 
Number of HIV patients 
on ARV treatment - To-
tal HIV Expenditure 
0.027 0.725 0.526 
GDP Growth (%) - Total 
HIV Domestic Expendi-
ture 
0.021 0.742 0.551 
Health Budget (million) 
- Total HIV Domestic 
Expenditure 
0.001 0.885 0.783 
Source: Secondary Data of NASA, 2019, World Bank, 2020 
& Indonesia Health Profile, 2019 
     Funds related to reducing discrimination or 
areas of conducive environment receive a fairly 
small proportion of spending. In 2017 this area 
spent USD 1,825,899 in funding or only around 
1.28%. Prevention and treatment still appear to 
be a national priority in AIDS response in the re-
gions while reducing stigma does not appear to 
be a priority judging by the 2017 and 2018 fund-
ing figures. Implementation of the country's fast 
track accelerates the achievement of: 1) reduc-
tion of new HIV infections, 2) Reducing AIDS-re-
lated deaths, 3) Eliminate HIV-related stigma 
and discrimination. Creating a conducive envi-
ronment (category 7) that supports this 3rd tar-
get, UNAIDS itself targets to reach at least 8% of 
spending in 2020.10 
     Countries need more stable and predictable 
sources of funding for HIV prevention, treat-
ment, and care. The trend of increasing domestic 
funds can be interpreted as growing independ-
ence and stability of the state in dealing with 
HIV/AIDS. However, the unbalanced allocation 
between prevention, treatment, and a conducive 
environment will make dependence on interna-
tional funds high. Prevention only gets a share of 
3.97% or as much as 2,916,105. In fact, Globally, 
the cost of prevention per infection is estimated 
at 3.923 USD. While the cost of treatment per 
person is estimated at 4,707 USD, then preven-
tion would save 784 USD for each preventable 
infection.11 
     Prevention priorities for key populations will 
be able to reduce cumulative HIV infections by 5 
million infections, reduce the number of People 
Living with HIV AIDS (PLWHA) by 3.1 million, re-
duce AIDS deaths by 40% and reduce HIV prev-
alence.11 Sustained domestic funding for 
HIV/AIDS is needed to achieve a robust program 
to tackle the HIV epidemic that will result in a re-
duction in cases in the long term. The high level 
of dependence on international funding, espe-
cially on prevention, makes it necessary to reor-
ganize the HIV/AIDS funding architecture to 
protect the sustainability of HIV funding.12 
     The increase in the government's contribu-
tion is directly proportional to the HIV/AIDS 
control program in Indonesia. Expenditures for 
HIV/AIDS control programs from the domestic 
budget continued to increase from 2010-2016. 
Similar trends are shown by reported HIV cases 
and ARV coverage in Indonesia. The value of the 




correlation study also showed a strong and sig-
nificant relationship between domestic spend-
ing on HIV/AIDS with reported cases (R=0.717, 
p=0.030) and ARV coverage (R=0.725, p=0.027). 
In this study, it is shown that sthe source of 
public funding from the central government 
spent on this program is largely expenditure by 
the Ministry of Health for treatment (91.48% in 
2017). Funds from the APBN are disbursed for 
the procurement of ARV drugs, OI, Reagents and 
the provision of HIV test kits every year. There 
was an increase in spending on ARV drugs, from 
18 million USD in 2015 to 65 million USD in 2016 
due to the policy of switching health programs. 
     The increase in the treatment budget is in line 
with the policy commitments shown since the 
first case was discovered until the implementa-
tion of the Sustainable Comprehensive Service 
for HIV-AIDS and Sexually Transmitted Infec-
tions (STIs).13-14 Strengthening treatment cover-
age is considered efficient but effective in sup-
pressing the epidemic. A modeling carried out in 
23 countries shows that a more efficient alloca-
tion of HIV resources can reduce cumulative HIV 
infections and reduce deaths caused by HIV/ 
AIDS.15 However, the current amount of funding 
is not sufficient to meet the targets of the na-
tional strategic plan, at least a 185% increase in 
budget is required to achieve the desired tar-
get.15 
     The country's economic growth in this study 
also shows a relationship with domestic spend-
ing on HIV/AIDS in Indonesia.Total HIV domes-
tic expenditure and GDP growth (%) have a 
strong relationship (R=0.742) with the contribu-
tion of the influence of the health budget of 
0.551% and p=0.021. These results are in line 
with a study conducted by Avila, et al in 125 low- 
and middle-income countries in 2013, the study 
found that GDP per capita and HIV prevalence 
were positively associated with increased levels 
of HIV expenditure from public sources.9 There 
was a 10 percent increase in HIV prevalence as-
sociated with a 2.5 percent increase in domestic 
funding for HIV.9 
     The rate of economic growth reflects a meas-
ure of its ability to maintain public health condi-
tions.16 This study indicates the country's ability 
and readiness to fund HIV/AIDS prevention, es-
pecially for treatment. Re-mapping of funding al-
locations, however, needs to be done. Funding 
for community-based prevention programs 
aimed at key populations is necessary and the 
development of a conducive environment needs 
to be allocated. 
     This study also shows a strong relationship 
between the health budget and domestic spend-
ing on HIV/AIDS. Total domestic HIV expendi-
ture and total health budget have a very strong 
relationship (R=0.885) with a contribution of 
78.3% of the health budget influence and a 
p=0.001. Financial capacity in dealing with 
HIV/AIDS is related to the availability of the 
health budget at the Ministry of Health. This is in 
line with research by Yang, dkk which confirms 
that the larger the health budget, the greater the 
support for the population affected by 
HIV/AIDS.17 However, the distribution of the 
proportion of the HIV/AIDS budget needs to face 
3 other budget priorities at the Ministry of 
Health, namely the handling of stunting, preva-
lence of tuberculosis, and elimination of malaria. 
     This study has several limitations. First, 
NASA's data collection at the sub-national level 
only covers eight to eleven provinces that have 
the highest HIV/AIDS prevalence. In addition, 
this data also does not explore independent 
funds issued by the community (out of pocket). 
Therefore, this result from NASA has the possi-
bility of a lower estimate than the actual one. In 
addition, this research design only looks at the 
relationship of the aggregated data without be-
ing able to determine what variables have the 
most influence. The last, there is no direct causal 
relationship between program expenditures and 
the independent variables studied in this study. 
CONCLUSION AND RECOMMENDATION 
     A sustainable HIV/AIDS control program is 
highly dependent on funding. The results of 
NASA's analysis for 2017-2018 show that the 
total expenditure of funds related to the 
HIV/AIDS program in 2017 was 143,053,754 
USD and decreased to 107,680,959 USD in 2018. 
Of the total expenditure, about 60% each came 
from public funding (APBN/APBD) and the 
remaining 35-40% comes from international 
partner institutions and the private sector. To 
achieve the target of 80% of funding sources 
coming from the public, intensive advocacy 
activities at all levels are needed to identify 
potential sources of public funding (including 




the Ministry of Finance, BAPPENAS, Ministry of 
Home Affairs); strengthening cross-sectoral 
capacity for planning HIV/AIDS prevention 
programs at each regional level and increasing 
the allocation of funds for HIV/AIDS prevention 
and control programs through related sectors 
and government funding mechanisms for Non-
Governmental Organizations; explore opportu-
nities for private sector partnerships or other 
forms of public-private collaboration; and the 
use of village funds for HIV/AIDS prevention and 
control programs. The last, HIV/AIDS funding 
architecture needs to be reorganized to protect 
the sustainability of HIV funding. 
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